⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL64072 | 0.74 | CYP3A4 (0.33) | — | |
| SCHEMBL27960253 | 0.73 | CYP3A4 (0.32) | — | |
| SCHEMBL28013804 | 0.73 | CYP3A4 (0.32) | — | |
| SCHEMBL28013221 | 0.73 | CYP3A4 (0.32) | — | |
| SCHEMBL3908846 | 0.73 | — | — | |
| SCHEMBL28819045 | 0.73 | CYP3A4 (0.32) | — | |
| SCHEMBL3955049 | 0.73 | — | — | |
| SCHEMBL30106704 | 0.73 | — | — | |
| SCHEMBL6131635 | 0.73 | — | — | |
| SCHEMBL1979559 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015126922-A2 | RAPID PHENOTYPE TESTS FOR ANTITUBERCULAR DRUG SENSITIVITY AND RESISTANCE | STC. UNM (US) | 2015-08-27 | — | — | WO | claimed |
| WO-2024175804-A1 | NUCLEAR TRANSPORT MODULATORS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-08-29 | — | — | WO | disclosed |
| CN-109507342-B | Method for determining nitroimidazole drug residues in blood sample | 中国检验检疫科学研究院 | 2021-11-16 | — | — | CN | disclosed |
| US-20170010272-A1 | RAPID PHENOTYPE TESTS FOR ANTITUBERCULAR DRUG SENSITIVITY AND RESISTANCE | TRIAD NATIONAL SECURITY, LLC | 2017-01-12 | — | — | US | disclosed |
| WO-2015126922-A2 | RAPID PHENOTYPE TESTS FOR ANTITUBERCULAR DRUG SENSITIVITY AND RESISTANCE | STC. UNM (US) | 2015-08-27 | — | — | WO | disclosed |
| EP-2101825-A2 | HYPOXIA-SELECTIVE, WEAKLY BASIC 2-NITROIMIDAZOLE DELIVERY AGENTS AND METHODS OF USE THEREOF | Natural Pharmacia International, Inc. (US) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008070336-A2 | HYPOXIA-SELECTIVE, WEAKLY BASIC 2-NITROIMIDAZOLE DELIVERY AGENTS AND METHODS OF USE THEREOF | NATURAL PHARMACIA INTERNATIONAL, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| EP-1537869-A2 | Radiosensibilizer and preparation thereof | Christian-Albrechts-Universität zu Kiel (DE) | 2005-06-08 | — | — | EP | disclosed |
| EP-0866793-B1 | NITROIMIDAZOLE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF | CHIRON CORP (US) | 2004-10-27 | — | — | EP | disclosed |
| US-6087358-A | BACTERICIDES TREATING PATHOGENIC INFECTIONS OF MYCOBACTERIA, CLOSTRIDIUM, CRYPTOSPORIDIUM OR HELICOBACTER AND MULTIDRUG-RESISTANT TUBERCULOSIS | PATHOGENESIS CORPORATION (US) | 2000-07-11 | — | — | US | disclosed |
| EP-0866793-A4 | — | — | 1998-10-07 | — | — | EP | disclosed |
| EP-0866793-A1 | NITROIMIDAZOLE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF | PATHOGENESIS CORPORATION (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997001562-A1 | NITROIMIDAZOLE ANTIBACTERIAL COMPOUNDS AND METHODS OF USE THEREOF | PATHOGENESIS CORPORATION (US) | 1997-01-16 | — | — | WO | disclosed |